India’s pharmaceutical industry is currently valued at approximately US$58 billion, with projections indicating growth to US$120-130 billion by 2030 and US$400-450 billion by 2047. Key factors driving this expansion include the rising prevalence of lifestyle-related diseases, an aging population, increased focus on holistic health and well-being, and the growing consumerization of healthcare.
India hosts the…
The pharmaceutical sector is showcasing growth daily, developing, introducing, and marketing pharmaceuticals products. Pharmaceutical products are the result of a variety of laws and regulations universally. The increasing demand for products and compliance with strict regulations made the pharmaceutical companies outsourcestrong Pharmaceutical Contract manufacturers.
As this industry follows multifaceted compliance as required by law and procedure,…
To maintain profitable and resilient operations, CEOs and COOs of pharma companies may need to make bold changes to their operations strategy as the industry navigates new challenges.
many pharmaceutical companies (pharmacos) deprioritized operations strategy in the face of competing business pressures. This is now changing. Factors such as the COVID-19 pandemic, inflation, geopolitics, new therapeutic…
